|
SRRM1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.572800E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.122400E-03 |
| Normal-vs-Stage2 |
9.300200E-03 |
| Normal-vs-Stage3 |
3.214600E-04 |
| Normal-vs-Stage4 |
4.05879999998415E-06 |
| Stage1-vs-Stage2 |
4.142000E-01 |
| Stage1-vs-Stage3 |
8.511800E-02 |
| Stage1-vs-Stage4 |
5.942300E-03 |
| Stage2-vs-Stage3 |
6.773600E-01 |
| Stage2-vs-Stage4 |
2.033200E-01 |
| Stage3-vs-Stage4 |
3.283200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.359400E-04 |
| Normal-vs-AfricanAmerican |
8.619200E-03 |
| Normal-vs-Asian |
2.946200E-02 |
| Caucasian-vs-AfricanAmerican |
8.685400E-01 |
| Caucasian-vs-Asian |
9.813200E-04 |
| AfricanAmerican-vs-Asian |
2.523200E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.002700E-04 |
| Normal-vs-Female |
8.024800E-03 |
| Male-vs-Female |
8.283700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.724700E-03 |
| Normal-vs-Age(41-60Yrs) |
7.101700E-03 |
| Normal-vs-Age(61-80Yrs) |
3.163200E-04 |
| Normal-vs-Age(81-100Yrs) |
9.827900E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.033400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.328000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.354400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.032600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.937800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.097000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.316400E-01 |
| Normal-vs-Grade 2 |
6.896400E-02 |
| Normal-vs-Grade 3 |
3.32069999997575E-06 |
| Normal-vs-Grade 4 |
1.47890000001816E-06 |
| Grade 1-vs-Grade 2 |
1.944170E-01 |
| Grade 1-vs-Grade 3 |
6.240300E-03 |
| Grade 1-vs-Grade 4 |
2.082900E-03 |
| Grade 2-vs-Grade 3 |
7.194400E-04 |
| Grade 2-vs-Grade 4 |
4.634500E-04 |
| Grade 3-vs-Grade 4 |
2.005600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.936800E-01 |
| Normal-vs-ccB subtype |
1.60562999999003E-05 |
| ccA subtype-vs-ccB subtype |
4.22280000000885E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.063380E-03 |
| Normal-vs-N1 |
9.675700E-03 |
| N0-vs-N1 |
4.432800E-01 |
|
|
